COMMUNIQUÉS West-GlobeNewswire

Teleflex Announces Real-World Data Demonstrating the Effectiveness of the UroLift® System to Treat Patients with Enlarged Prostate
21/03/2019
Findings Presented at European Association of Urology Show Consistent Positive Results for Minimally Invasive UroLift System Treatment WAYNE, Pa., March 21, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) [...]
Exactus Appoints Emiliano Aloi as President
21/03/2019
DELRAY BEACH, Fla., March 21, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB:EXDI; OTCQB:EXDID ), a healthcare company pursuing opportunities in Hemp derived, Cannabidiol (CBD) products, announced it has appointed [...]
Bavarian Nordic Announces Annual Report 2018
21/03/2019
Copenhagen, March 21, 2019 (GLOBE NEWSWIRE) -- COPENHAGEN, Denmark, March 21, 2019 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its Annual Report for 2018. Below is a summary of business progress, [...]
New Board starts reviewing the situation in Oasmia
21/03/2019
March 19th, the Extra General Meeting in Oasmia elected a new Board on the initiative of the main owner Arwidsro. The EGM was well represented with over a hundred participating shareholders and over 400 proxies. Jörgen [...]
Dr. Martin Edwards Joins Verona Pharma as Non-Executive Director
21/03/2019
LONDON, March 21, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Bavarian Nordic Awards Restricted Stock Units to Executive Management
21/03/2019
COPENHAGEN, Denmark, March 21, 2019 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company has awarded restricted stock units to members of the Executive Management. The Board of Directors of [...]
Neovacs to present the preclinical results of its therapeutic vaccine candidate IL-4 / IL-13 Kinoid at Keystone Congress
21/03/2019
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS TO PRESENT THE PRECLINICAL RESULTS OF ITS THERAPEUTIC VACCINE CANDIDATE IL-4 / IL-13 KINOID AT KEYSTONE CONGRESS: “Origins of Allergic Disease: Microbial, Epithelial [...]
Néovacs présente les résultats précliniques de son candidat vaccin thérapeutique IL-4 / IL-13 Kinoïde au Congrès Keystone
21/03/2019
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS PRÉSENTE LES RESULTATS PR É CLINIQUES DE SON CANDIDAT VACCIN TH É RAPEUTIQUE IL-4/IL-13 KINO Ϊ DE AU CONGRÈS KEYSTONE : « Origines des maladies [...]
Addex to Participate in the BIOEurope Spring Conference
21/03/2019
Geneva, Switzerland, March 21, 2019 – Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, announced today that CEO, Tim Dyer and Head of Discovery [...]
IBA annonce ses résultats annuels pour 2018
21/03/2019
Retour à la profitabilité au deuxième semestre 2018 Louvain-La-Neuve, Belgique, le 21 mars 2019 - IBA ( Ion Beam Applications SA , EURONEXT), le premier fournisseur mondial de solutions de protonthérapie pour le [...]
IBA Reports Full Year 2018 Results
21/03/2019
Return to profitability in H2 Louvain-La-Neuve, Belgium, March 21, 2019 - IBA ( Ion Beam Applications SA , EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces [...]
Align University Training Institute Opens in Shanghai, China
21/03/2019
Align’s Second Training Facility in China Reflects Company’s Continued Commitment to Clinical Education SHANGHAI, China and SAN JOSE, Calif., March 20, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN), [...]
Genomics England and Cambridge Cancer Genomics (CCG.ai) announce immunotherapy partnership
21/03/2019
Partnership announced to improve access to, and the effectiveness of, immunotherapies in lung and colorectal cancers CAMBRIDGE, United Kingdom, March 20, 2019 (GLOBE NEWSWIRE) -- Genomics England, the Department of [...]
MatriSys Bioscience announces successful FDA Pre-IND review and Phase 2 plans for MSB-01, a revolutionary human-microbiome based treatment for Atopic Dermatitis
21/03/2019
SAN DIEGO, March 20, 2019 (GLOBE NEWSWIRE) -- MatriSys Bioscience, Inc., a clinical stage biotechnology company developing rationally designed microbiome therapeutics to treat the top five skin diseases, today announced [...]
NOTICE TO CONVENE ORDINARY GENERAL MEETING
20/03/2019
INDKALDELSE TIL ORDINÆR GENERALFORSAMLING NOTICE TO CONVENE ORDINARY GENERAL MEETING KALLELSE TILL ÅRSSTÄMMA Der indkaldes herved til ordinær generalforsamling i Oncology Venture A/S (“ Selskabet “): Notice is hereby [...]
Galapagos increases share capital through warrant exercises
20/03/2019
Mechelen, Belgium; 20 March 2019, 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 149,370 new ordinary [...]
Portola Pharmaceuticals’ Co-Founder Dr. Charles Homcy Retires from the Company’s Board of Directors
20/03/2019
SOUTH SAN FRANCISCO, Calif., March 20, 2019 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today announced that on March 15, 2019 Charles Homcy, M.D., informed the Board of his decision to retire [...]
PROJECT HOPE RESPONDS TO DEADLY MOZAMBIQUE CYCLONE
20/03/2019
“Cyclone Idai was deadly. If we don’t act now, the aftermath will be deadlier.” Millwood, Virginia, March 20, 2019 (GLOBE NEWSWIRE) -- Project HOPE is on the ground in Mozambique working as quickly as possible to gather [...]
Kane Biotech Schedules Full Year 2018 Earnings Conference Call and Business Update
20/03/2019
Conference Call to be held Tuesday, March 26 at 4:00pm ET WINNIPEG, Manitoba, March 20, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), is pleased to announce today that it [...]

Pages